… receptor (ER)–positive, HER2-negative metastatic breast cancer following disease progression on frontline … with] ER-positive, HER2-negative metastatic breast cancer,” Chia said in conclusion. Disclosures …

… receptor–positive/HER2-positive metastatic breast cancer. The randomized, international, open-label … receptor–positive/HER2-positive metastatic breast cancer, the current standard of care …

… and rendering the management of metastatic breast cancer more effective and patient-centered …

… treatment of some people with metastatic breast cancer and help their tumors remain … to better treatments, people with metastatic breast cancer now live about five years … has lived with estrogen-driven metastatic breast cancer since 2013, called the results …

… locally advanced or metastatic breast cancer upon emergence of … locally advanced or metastatic breast cancer, previously treated … and HER2-ultralow metastatic breast cancer, and are exploring … positive, HER2-negative metastatic breast cancer. J Cancer. 2020 …

… huge part of living with metastatic breast cancer. [The study] uses a technology … hormone receptor–positive, HER2-negative metastatic breast cancer in patients with ESR1 mutations …

… trial showed that women with metastatic breast cancer who went to a weekly …

… were chemotherapy-naïve in the metastatic breast cancer setting. Prior lines of … for metastatic breast cancer, or 1 line of therapy for metastatic breast cancer and … , hormone receptor–positive (HR+) metastatic breast cancer (mBC) in DESTINY-Breast06 ( …

… undergoing infusion therapy for metastatic breast cancer. These findings were highlighted … therapies to patients with metastatic breast cancer may experience challenges such … infusion therapy management in metastatic breast cancer: real-world pilot study …

… -positive, HER2-negative advanced or metastatic breast cancer in the global VERITAC-2 …